Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 534

The report shows a surprising diet to be healthy and live longer.

Summary: Comparing the Atkins, Rosedale, Paleo, Mediterranean and DASH Diet plans, researchers report on the healthiest options. [This article first appeared on the LongevityFacts website. Author: Brady Hartman.]

Despite all the advances made with lifespan-extending drugs, a healthy diet remains as one of the best ways to stay healthy and live longer. While many dietary regimens can help us lose weight, few people recognize that some of these are downright unhealthy. However, given the multitude of meal plans – such as the Atkins, Rosedale, Paleo, DASH, Mediterranean and the ‘USDA MyFoodPlate’ – which diet is the best for a slim figure and optimal health?

The optimal diet is one that can help us live longer healthier lives while staying slim. Once a person has slimmed down, following a balanced diet that provides optimal nutrition will help us keep live longer and in better health.

Continue reading “Report on Doctor’s Healthiest Diet” | >

Can anyone suggest how we can prevent this from happening to us?

Summary: Air pollution and global warming will ascend to the top cause of death in the next three decades, say researchers from the University of Southern California. The scientists add that the polluted air will lead to a rise in lung disease, heart attacks, and strokes. [This article first appeared on the LongevityFacts.com website. Author: Brady Hartman.]

A pair of expert scientists from the University of Southern California (USC) in Los Angeles says that global warming and air pollution will ascend to the top cause of death due to “ischemic heart disease, stroke, cancer, chronic lower respiratory disease.”

Citing cite nearly a dozen studies on the effects of air pollution on human health, experts Caleb E. Finch, Ph.D. a molecular biologist and Edward L. Schneider, MD predict that.

Continue reading “Scientists Say Air Pollution Will Be Our Top Killer by 2050” | >

The end of the year is approaching, and as we prepare for the celebrations for the new year, what could be better than sitting down with a warm drink and recapping 2017 in the world of rejuvenation biotechnology?

Winter kick-off

This year has been pretty intense, with a lot going on both at LEAF and in the rest of the community. January saw the launch of the LEAF website, shortly followed by both the Lifeboat Foundation and Trust me – I’m a biologist partnering with us. Given that it’s been only a year, we’re amazed at how enthusiastic and supportive the community has been—and how fast it has grown, with nearly 30,000 Facebook followers late in December! We’re also very grateful to our friends at Fight Aging! for their encouragement, support, and appreciation for our work, including honoring us by featuring it on their website!

Read more

Currently have telomerase which can immortalize human cells in a petri dish. Currently we have stem cells and we can take regular cells even from someone who is 100 years old and we can deprogram the cells back to a pluripotent stem cell state. This is effectively de-aging the cells. There is an effort by some researchers (not Dr West) to achieve partial reprogramming of cells. This would be to use the reprogramming mechanisms to de-age cells while retaining differentiation.

Dr West mentions in the fifth video that he strongly disapproves of current stem cell treatment centers.

Dr. West notes that people did not believe that immortalizing human cells (even in a petri dish was possible). This was a belief held until the 1980s. Even Dr. Hayflick thought it was extremely unlikely to be achieved. Hayflick had found over 300 changes in the cells as they divided and reached their limit of division.

Read more

Recently pharma firms have released new diabetes treatments, including one in the past week. What’s more, a promising new therapy that attacks the cause of type 2 diabetes at its roots is in the development pipeline.

Summary: Recently pharmaceutical firms have released new diabetes treatments, including one in the past week. Moreover, a promising new therapy that attacks the root cause of type 2 diabetes is in the development pipeline. [This article first appeared on the LongevityFacts.com website. Author: Brady Hartman. ]

The CDC recently shocked the public when they reported that 40% of Americans walking around today would develop type 2 diabetes.

Many people develop type 2 diabetes as they age because their body’s response to insulin – the hormone that controls sugar levels – gets weaker.

Continue reading “Breakthroughs for Diabetes Treatments” | >

In a paradigm shift, scientists are starting to regard respiratory disease as a disease of aging and scientists at the Mayo Clinic reversed symptoms of a lung disease in mice using age-reversing senolytic compounds. In addition to senolytics, researchers are developing other treatments for respiratory conditions such as gene therapy.

Summary: In a paradigm shift, scientists are starting to regard respiratory disease as a disease of aging and scientists at the Mayo Clinic reversed symptoms of a lung disease in mice using age-reversing senolytic compounds. In addition to senolytics, researchers are developing other treatments for respiratory conditions such as gene therapy. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman.]

All of us – both smokers and non-smokers alike – will lose significant lung capacity as we age. Scientists at the Mayo Clinic have developed a promising treatment that rejuvenates the damaged lungs of mice using anti-aging compounds called senolytics.

The Mayo Clinic researchers showed evidence linking the biology of aging with idiopathic pulmonary fibrosis (IPF), a disease of aging that impairs lung function and causes fatigue, shortness of breath, declining quality of life, and, ultimately, death. The Mayo Clinic team showed that the lungs of human IPF patients are full of senescent cells, and treatment with senolytics reversed symptoms of the lung disease in mice. Moreover, because senolytics have general age-reversing effects, the Mayo researchers hope to test the therapy on seniors with IPF as well as other lung diseases of aging.

Continue reading “Breakthrough Cures for Respiratory Diseases and COPD in the Pipeline” | >

Elizabeth Parrish is a proponent of controversial ideas. Rankled by barriers to trials on potential life-enhancing treatments, she used herself as a guinea pig and says the results have borne fruit – but she has irked the science community in the process.

Experimenting on herself didn’t go down well with scientists, but Elizabeth Parrish is convinced gene therapy can increase the length and quality of our lives, and wants early approval for treatments to stem ‘planet’s biggest killer’.

Read more

Some 50,000 people in the U.S. are diagnosed with Parkinson’s disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years as average age of onset. Falls and fall-related injuries are a major issue for people with Parkinson’s?up to 70 percent of advanced PD patients fall at least once a year and two-thirds suffer recurring falls. These fall rates are twice as high as those of adults of comparable age, so improving balance in patients with Parkinson’s would provide a major health advantage.

Sunil Agrawal, professor of mechanical engineering and of rehabilitation and regenerative medicine at Columbia Engineering, along with Dario Martelli, a post-doctoral researcher in his group, have been working on this issue with Movement Disorders faculty from the department of neurology at Columbia University Medical Center?Stanley Fahn, a leading expert in Parkinson’s, and Un Jung Kang, division director, and Movement Disorder Fellow Lan Luo. In their latest study, published today in Scientific Reports, the team looked at whether or not Parkinson’s disease affects patients’ balance and diminishes their ability to react and adapt to walking with perturbations. The researchers found that the ability to adapt to multiple perturbations or to modify responses to changing amplitudes or directions was not affected by PD; both the Parkinson’s and the healthy subjects controlled their reactive strategies in the same way.

Read more